CONTRAVISORY INVESTMENT MANAGEMENT, INC.

Position in JNJ — Johnson & Johnson

CIK 1365707 Norwell, MA

Position in JNJ

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,102,483

+$75,591 QoQ

Shares Held

4,341

+3.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#2,921

of 4,664 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CONTRAVISORY INVESTMENT MANAGEMENT, INC. holds $32,212,697 across 8 Drug Manufacturers - General names. JNJ ranks #5 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	76,643	$9,848,625
2	BIIB	Biogen Inc.	44,329	$9,577,723
3	PFE	Pfizer Inc	299,290	$7,206,903
4	LLY	ELI LILLY & Co	2,955	$3,544,315
5	JNJ	Johnson & Johnson This page	4,341	$1,102,483
6	GILD	Gilead Sciences, Inc.	5,737	$724,812
7	ABBV	AbbVie Inc.	777	$195,524
8	AMGN	Amgen Inc	34	$12,312

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,102,483	4,341	+3.3%	Shares	Sole	2026-07-09
2026-03-31	$1,026,892	4,201	-4.8%	Shares	Sole	2026-04-20
2025-12-31	$912,856	4,411	+5279.3%	Shares	Sole	2026-01-12
2025-09-30	$15,204	82	+173.3%	Shares	Sole	2025-10-09
2025-06-30	$4,582	30	+328.6%	Shares	Sole	2025-07-10
2025-03-31	$1,160	7	0.0%	Shares	Sole	2025-04-10
2024-12-31	$1,012	7	-99.7%	Shares	Sole	2025-01-14
2023-03-31	$321,780	2,076	-6.5%	Shares	Sole	2023-04-12
2022-12-31	$392,339	2,221	+15.9%	Shares	Sole	2023-01-13
2022-09-30	$313,161	1,917	+6.4%	Shares	Sole	2022-10-12
2022-06-30	$319,695	1,801	+59933.3%	Shares	Sole	2022-07-13
2020-09-30	$446	3	0.0%	Shares	Sole	2020-10-08
2020-06-30	$421	3	0.0%	Shares	Sole	2020-07-09
2020-03-31	$393	3	—	Shares	Sole	2020-04-09
No filing history on record for this holder in this stock.